my account log out | |
Letrazole(Femara) |
Create: 07/12/2016 |
Expired Date: | never |
Category: | Hormone [Chemical] |
Message: | Keywords:Letrozole,FEMARA,LETROZOL,LETRAZOLE,Lelrozol , 112809-51-5, letrozolex Product name: Letrozole CAS: 112809-51-5 MF: C17H11N5 MW: 285.3 Description: Letrozole (INN, trade name Femara) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery. Letrozole is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. |
City: | Beijing Beijing[CN] |
Location: | |
Nov 27 2016 | 16α-methyl Epoxide 21-Acetate | 535 | |
Nov 27 2016 | Dexamethasone Palmitate | 506 | |
Nov 27 2016 | Dexamethasone-21-Acetate | 535 | |
Nov 27 2016 | Dexamethasone | 542 | |
Nov 27 2016 | 16α-HYDROXY-PREDNISONLONE | 543 | |
Nov 27 2016 | Prednisolone Sodium Phosphate | 538 | |
Nov 27 2016 | Prednisone 21-acetate | 561 | |
Nov 27 2016 | Prednisolone | 504 | |
Nov 27 2016 | Meprednisone | 542 | |
Nov 27 2016 | Corticosteroids | 502 |
Copyright © toextrade Inc. All rights reserved. Contact us |